Canndoc has been pioneering Pharma-Grade medical cannabis for more than 11 years. Over the years, Canndoc provided more than ... 500,000 doses to 15,000 patients, establishing its position as a venerable player in this global industry, demonstrating significant expertise across the entire value chain from research, cultivation, and processing, to product development and advanced clinical trials pipeline initiation. Driven by the mission of meeting patients’ needs and improving their quality of life, Canndoc holds product efficacy to be of paramount importance, delivering Good Manufacturing Practice (GMP) pharma-grade cannabis solutions to achieve better patient health and treatment outcomes. read more